68例初次诊断的2型糖尿病患者随机分观察组34例,用胰岛素泵持续输注诺和灵R,另34例分次皮下注射。结果观察组血糖达标时间明显短于对照组,前者胰岛素用量、低血糖发生频率显著低于后者(P<0.05)且疗效持久。结论对新诊断的T2DM尽早使用胰岛素持续注射治疗,有利于残存β细胞功能的保护。 Sixty-four patients with newly diagnosed type 2 diabetes were randomly divided into observation group (34 cases), continuous infusion of Novolin (R) with insulin pump and subcutaneous injection of 34 cases. Results The observation group had significantly shorter blood glucose time than the control group. The former had significantly lower insulin dosage and hypoglycemia than the latter (P <0.05). CONCLUSIONS As soon as possible, the newly diagnosed T2DM with insulin continuous injection therapy is conducive to the protection of residual β-cell function.